|
SLC41A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.191800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.442770E-03 |
| Normal-vs-Stage2 |
3.745600E-01 |
| Normal-vs-Stage3 |
3.610600E-04 |
| Normal-vs-Stage4 |
2.939900E-02 |
| Stage1-vs-Stage2 |
1.120240E-01 |
| Stage1-vs-Stage3 |
1.832250E-01 |
| Stage1-vs-Stage4 |
9.632800E-01 |
| Stage2-vs-Stage3 |
1.609610E-02 |
| Stage2-vs-Stage4 |
2.181800E-01 |
| Stage3-vs-Stage4 |
3.386600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.26719999999859E-05 |
| Normal-vs-AfricanAmerican |
7.327200E-01 |
| Normal-vs-Asian |
2.023200E-01 |
| Caucasian-vs-AfricanAmerican |
5.239900E-03 |
| Caucasian-vs-Asian |
8.362000E-02 |
| AfricanAmerican-vs-Asian |
2.331800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.57530000000672E-05 |
| Normal-vs-Female |
4.222800E-03 |
| Male-vs-Female |
3.184300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.819950E-03 |
| Normal-vs-Age(41-60Yrs) |
5.521000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.642490E-02 |
| Normal-vs-Age(81-100Yrs) |
7.014500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.151600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.987200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.273000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.732200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.710430E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.578560E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.168800E-04 |
| Classical-VS-Follicular |
5.242400E-02 |
| Classical-VS-Other |
1.450410E-01 |
| Classical-VS-Normal |
2.120300E-03 |
| Tall-VS-Follicular |
1.52652999999559E-05 |
| Tall-VS-Other |
9.738000E-01 |
| Tall-VS-Normal |
2.18860000011922E-07 |
| Follicular-VS-Other |
5.452200E-02 |
| Follicular-VS-Normal |
3.229000E-01 |
| Other-VS-Normal |
4.320700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.359100E-03 |
| Normal-vs-N1 |
7.765000E-04 |
| N0-vs-N1 |
7.439700E-02 |
|
|
